From July 1, 2023 to October 9, 2023, the company has repurchased 30,000 shares, representing 0.005243% for CNY 0.49 million. With this, the company has completed the repurchase of 9,865,793 shares, representing 1.7% for CNY 200 million under the buyback announced on October 21, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.6 CNY | -1.01% | +0.68% | +5.37% |
04-26 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-29 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.37% | 1.64B | |
-1.29% | 12.64B | |
-0.47% | 8.46B | |
+5.68% | 5.66B | |
+22.61% | 5.27B | |
-2.03% | 4.49B | |
-53.56% | 3.11B | |
+19.30% | 2.87B | |
+33.07% | 2.31B | |
-8.42% | 2.23B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.